✦ LIBER ✦

A phase I–II study of docetaxel (D) and gemcitabine (G) combination in patients (pts) with non-small cell lung cancer (NSCLC)

✍ Scribed by Quantin, X; Rebattu, P; Pujol, J; Morere, J; Azarian, M.R; Khial, F; Dumortier, A; Schuller-Lebeau, M.P

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of docetaxel (D) and ge

✍ Agelaki, S.; Papadakis, E.; Tsiafaki, X.; Rapti, A.; Toubis, M.; Bania, E.; Kalb 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 158 KB

1070 Phase II trial with docetaxel in pa

✍ Latreille, J.; Laberge, F.; Viallet, J.; Maksymiuk, A.; Shepherd, F.; Gelmon, K. 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 163 KB

1081 Gemcitabine combined with cisplatin

✍ Steward, W.P.; Dunlop, D.J.; Cameron, C.; Talbot, D.C.; Kleisbauer, J.-P.; Thoma 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 158 KB

Phase I/II trial of gemcitabine plus doc

✍ Valerie Israel; Scott T. Tagawa; Terry Snyder; Susan Jeffers; Derek Raghavan 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 66 KB

1064 Gemcitabine-cisplatin combination i

✍ Crinò, L.; Seagliotti, G.; Marangolo, M.; Figoli, F.; Clerici, M.; De Marinis, F 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 160 KB

Results of the phase I-II study of gemci

✍ Faivre, S; Monnerat, C; Raymond, E; Taieb, J; Adi Vago, N; Vicente-Azevedo, J; R 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 105 KB